Phibro Animal Health · 8 hours ago
3rd Shift Production Associate
Phibro Animal Health Corporation is a global manufacturer of medicated feed additives and nutrition solutions. The 3rd Shift Production Associate will assist in various aspects of the trace mineral production process to ensure efficient operations and product quality.
AgricultureFarmers MarketFood Processing
Responsibilities
Add the appropriate ingredient and amount to the designated hand add station according to batching software instructions
Effectively operate bag and/or tote packaging equipment
Replenish ingredient delivery systems
Prepare sampling materials for quality control purposes
Operate forklift to facilitate the movement of materials required for production
Inspect, set up, and test equipment including scales, load cells, and magnets
Perform housekeeping and general cleaning duties to ensure plant and employee safety
Take personal responsibility for the safety and quality of assigned tasks
Work effectively as part of a high-performance team to achieve production goals
Qualification
Required
High school diploma or equivalent
Strong communication skills to effectively interact with team members and follow instructions
Ability to operate packaging and material handling equipment efficiently
Physically able to lift 55 lbs. on a continuous basis
Must be able to stand, climb steps, bend, and walk throughout the shift
Preferred
Experience in operating industrial equipment such as forklifts and pallet jacks is desired
Company
Phibro Animal Health
Phibro Animal Health Corporation is dedicated to helping meet the growing demand for animal protein.
H1B Sponsorship
Phibro Animal Health has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (1)
Funding
Current Stage
Public CompanyTotal Funding
$550M2021-04-22Post Ipo Debt· $550M
2014-04-11IPO
2008-03-01Acquired
Recent News
2025-12-18
2025-12-07
2025-11-08
Company data provided by crunchbase